Researchers examine the preterm newborns' gut microbiota.

Published Date: 27 Apr 2023

In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.

Read Full News

Latest News

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Fostering Independence

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Fostering Independence

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Protecting Joint Health and Long-Term Outcomes

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Protecting Joint Health and Long-Term Outcomes

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Individualizing Prophylaxis

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Individualizing Prophylaxis

Advancing Pediatric Hemophilia Care in the Non-Factor Era: From Factor Replacement to Rebalancing Therapies

Advancing Pediatric Hemophilia Care in the Non-Factor Era: From Factor Replacement to Rebalancing Therapies

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Newborn Girls Appear Less Likely to Get Vitamin K, Hepatitis B Shots

Relationship stronger for vitamin K; may be tied to circumcision

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Latest News

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Fostering Independence

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Protecting Joint Health and Long-Term Outcomes

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Individualizing Prophylaxis

Advancing Pediatric Hemophilia Care in the Non-Factor Era: From Factor Replacement to Rebalancing Therapies

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Relationship stronger for vitamin K; may be tied to circumcision

News All Time

'Tiniest Penis' Fundraiser; Flu Vaccine Maker Investigated; FDA Rejects Gout Drug

Health news and commentary gathered by MedPage Today staff

Efforts to End School Vaccine Mandates Hit a Wall in Florida

The outcome could offer insights into such efforts' chances in other states

RFK Jr. Hasn't Restored Trust in Public Health, Cassidy Says

Senate HELP Committee chair also claims "paperwork" is holding up federal health appointments

Vitamin A Linked to Better Lung Function in Kids, Adults With Asthma

Vitamin D levels correlated with lung function only in adults

Pediatricians Should Be Alert for This Deadly Infection in Kids

Brain-eating P. dendritiformis infections could become more common, researcher warns

What Caused This Infant's 'Flaking Paint' Skin Rash?

Disease is common in poverty-stricken areas; cases in U.S. tied to "food fads," restricted diets

US FDA Approves Vertex's Gene Therapy for Sickle Cell Disease in Children as Young as Two

The U.S. Food and Drug Administration approved expanded use of Vertex Pharmaceuticals' gene therapy in ⁠children as young as two with inherited blood disorders, including...

US FDA Declines Lantheus’ Tumor Imaging Kit Over Third-party Manufacturing Issues

The U.S. Food and Drug Administration declined to approve Lantheus Holdings’ diagnostic ⁠imaging kit for types of cancer tumors, citing unresolved issues at a third-party...

Habit Score Tied to Improved Inhaled Drug Adherence in CF

Habit formation is a key modifiable factor for adherence to inhaled therapy in adults with cystic fibrosis; age, socioeconomic status, neurodivergence and complex regimens also influence adherence.

Ginkgo biloba Adds an Edge in Pediatric Enuresis

Ginkgo biloba extract, alone or in combination with desmopressin, is safe and effective for treating monosymptomatic nocturnal enuresis in children, a trial shows.

Counsel Families on Prevention of Drowning

American Academy of Pediatrics issued a policy statement updating guidance on how to counsel patients and families about preventing drowning.

Digital Addiction: Can an AI App Detect Warning Signs?

Researchers develop an AI tool that assesses smartphone interactions and flags patterns associated with vulnerability to compulsive digital behaviors.

Lead Exposure Disparities Persist at State Level

Although blood lead levels in children have decreased nationally, state values indicate high levels in some populations.

Positive Childhood Experiences Linked to Adult Wellbeing

Adverse childhood experiences set the stage for life later on.

FDA Declines to Approve Cingulate's ADHD Treatment Over Manufacturing Issues

Drug developer Cingulate said on Tuesday the U.S. Food and Drug Administration declined to approve its treatment for ⁠attention deficit hyperactivity disorder, citing...

US Senator Durbin Urges RFK Jr. to Resist Easing Vape Rules

U.S. Senator Dick Durbin urged Health Secretary Robert F. Kennedy Jr. on Wednesday to resist an easing of rules on ⁠flavoured vapes, saying the moves were short-sighted and...

Recommended News For You

Do I qualify for a cancer clinical trial?

Can Oncotype Predict Recurrence Risk in Older BC Patients?

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma

AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC

Recommended Articles For You

Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment 

Emerging Frameworks in Oncology in Clinical Decision-Making 

The Millionaire's Battle: Does Mark Cuban Have Cancer? 

Introduction to Immune Thrombocytopenic Purpura 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

CAR-T for Chronic Lymphocytic Leukemia Receives FDA Approval.

2.

Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients

3.

PSA Screening May Modestly Curb Prostate Cancer Deaths

4.

Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.

5.

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

1.

Exploring New Treatment Options for Hemophilia: A Journey into the Unknown

2.

Understanding Mean Corpuscular Volume: A Comprehensive Guide 

3.

Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy

4.

Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management

5.

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

2.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

3.

Navigating the Complexities of Ph Negative ALL - Part XV

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

5.

Efficient Management of First line ALK-rearranged NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot